BA
Bristlecone Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Sell |
1,507
-103
| -6% | -$19.1K | 0.02% | 193 |
|
|
2025
Q1 | $337K | Sell |
1,610
-255
| -14% | -$53.4K | 0.03% | 227 |
|
|
2024
Q4 | $331K | Buy |
1,865
+350
| +23% | +$62.2K | 0.03% | 230 |
|
|
2024
Q3 | $299K | Sell |
1,515
-286
| -16% | -$56.5K | 0.02% | 240 |
|
|
2024
Q2 | $309K | Sell |
1,801
-120
| -6% | -$20.6K | 0.03% | 228 |
|
|
2024
Q1 | $350K | Hold |
1,921
| – | – | 0.03% | 215 |
|
|
2023
Q4 | $298K | Buy |
1,921
+181
| +10% | +$28.1K | 0.03% | 227 |
|
|
2023
Q3 | $259K | Sell |
1,740
-8
| -0.5% | -$1.19K | 0.03% | 224 |
|
|
2023
Q2 | $236K | Buy |
1,748
+4
| +0.2% | +$539 | 0.02% | 244 |
|
|
2023
Q1 | $278K | Sell |
1,744
-267
| -13% | -$42.6K | 0.03% | 219 |
|
|
2022
Q4 | $325K | Sell |
2,011
-382
| -16% | -$61.7K | 0.04% | 200 |
|
|
2022
Q3 | $321K | Sell |
2,393
-47
| -2% | -$6.31K | 0.04% | 195 |
|
|
2022
Q2 | $374K | Sell |
2,440
-4,344
| -64% | -$666K | 0.05% | 189 |
|
|
2022
Q1 | $1.1M | Sell |
6,784
-8
| -0.1% | -$1.3K | 0.14% | 115 |
|
|
2021
Q4 | $920K | Buy |
6,792
+2,125
| +46% | +$288K | 0.11% | 129 |
|
|
2021
Q3 | $503K | Buy |
4,667
+141
| +3% | +$15.2K | 0.07% | 153 |
|
|
2021
Q2 | $510K | Buy |
4,526
+554
| +14% | +$62.4K | 0.07% | 147 |
|
|
2021
Q1 | $430K | Buy |
+3,972
| New | +$430K | 0.07% | 150 |
|
|
2020
Q1 | – | Sell |
-5,938
| Closed | -$526K | – | 146 |
|
|
2019
Q4 | $526K | Buy |
+5,938
| New | +$526K | 0.11% | 132 |
|
|
2019
Q3 | – | Sell |
-5,336
| Closed | -$388K | – | 136 |
|
|
2019
Q2 | $388K | Buy |
+5,336
| New | +$388K | 0.09% | 136 |
|
|
2017
Q4 | – | Sell |
-1,275
| Closed | -$113K | – | 145 |
|
|
2017
Q3 | $113K | Buy |
+1,275
| New | +$113K | 0.04% | 162 |
|